A Phase 2 Study of Magrolimab Combination Therapy in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Elevate Hnscc
AuthID
P-00Z-3SJ
P-00Z-3SJ
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service